Thromb Haemost 2019; 119(08): 1321-1331
DOI: 10.1055/s-0039-1692422
Cellular Haemostasis and Platelets
Georg Thieme Verlag KG Stuttgart · New York

Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice

Vaishali V. Inamdar
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
,
John C. Kostyak
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
,
Rachit Badolia
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
,
Carol A. Dangelmaier
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
,
Bhanu Kanth Manne
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
,
Akruti Patel
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
,
Soochong Kim
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
,
Satya P. Kunapuli
1   Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
2   Department of Physiology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
3   Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

10. August 2018

16. April 2019

Publikationsdatum:
21. Juni 2019 (online)

Abstract

Background and Objective CD45 is a receptor protein tyrosine phosphatase present on the surface of all hematopoietic cells except for erythrocytes and platelets. Proteomics studies, however, have demonstrated the presence of a CD45 c-terminal catalytic peptide in platelets. Therefore, we investigated the functional role of this truncated isoform of CD45 in platelets, which contains the c-terminal catalytic domain but lacks the extracellular region.

Methods and Results We used an antibody specific to the c-terminus of CD45 to confirm the presence of a truncated CD45 isoform in platelets. We also examined ex vivo and in vivo platelet function using CD45 knockout (KO) mice. Aggregation and secretion mediated by the glycoprotein VI (GPVI) receptor was impaired in CD45 KO platelets. Consequently, CD45 KO mice had impaired hemostasis indicated by increased tail bleeding times. Also, using a model of pulmonary embolism we showed that CD45 KO mice had defective in vivo thrombus formation. Next, we investigated whether or not the truncated isoform of CD45 had a role in GPVI signaling. The full-length isoform of CD45 is known to regulate Src family kinase (SFK) activation in lymphocytes. We find a similar role for the truncated isoform of CD45 in platelets. SFK activation was impaired downstream of the GPVI receptor in the CD45 KO murine platelets. Consequently, Syk, PLCγ2, and pleckstrin phosphorylations were also impaired in CD45 KO murine platelets.

Conclusion We conclude that the truncated CD45 isoform regulates GPVI-mediated signaling and platelet functional responses by regulating SFK activation.

Authors' Contributions

V.V.I. designed and performed experiments, analyzed and interpreted data, and wrote the manuscript; J.C.K. performed experiments, analyzed data, and edited the manuscript. R.B., C.A.D., B.K.M., A.P., and S.K. performed experiments. S.P.K. designed experiments, analyzed data, and interpreted data.


Supplementary Material

 
  • References

  • 1 Li Z, Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30 (12) 2341-2349
  • 2 Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood 2014; 124 (13) 2013-2024
  • 3 Roskoski Jr R. Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005; 331 (01) 1-14
  • 4 Newman DK. The Y's that bind: negative regulators of Src family kinase activity in platelets. J Thromb Haemost 2009; 7 (Suppl. 01) 195-199
  • 5 Okada M. Regulation of the SRC family kinases by Csk. Int J Biol Sci 2012; 8 (10) 1385-1397
  • 6 Pumiglia KM, Lau LF, Huang CK, Burroughs S, Feinstein MB. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Biochem J 1992; 286 (Pt 2): 441-449
  • 7 Frangioni JV, Oda A, Smith M, Salzman EW, Neel BG. Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J 1993; 12 (12) 4843-4856
  • 8 Ragab A, Bodin S, Viala C, Chap H, Payrastre B, Ragab-Thomas J. The tyrosine phosphatase 1B regulates linker for activation of T-cell phosphorylation and platelet aggregation upon FcgammaRIIa cross-linking. J Biol Chem 2003; 278 (42) 40923-40932
  • 9 Kuchay SM, Kim N, Grunz EA, Fay WP, Chishti AH. Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets. Mol Cell Biol 2007; 27 (17) 6038-6052
  • 10 Ellison S, Mori J, Barr AJ, Senis YA. CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases. J Thromb Haemost 2010; 8 (07) 1575-1583
  • 11 Saunders AE, Johnson P. Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45. Cell Signal 2010; 22 (03) 339-348
  • 12 Okumura M, Matthews RJ, Robb B, Litman GW, Bork P, Thomas ML. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J Immunol (Baltimore, Md: 1950) 1996; 157 (04) 1569-1575
  • 13 Desai DM, Sap J, Silvennoinen O, Schlessinger J, Weiss A. The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation. EMBO J 1994; 13 (17) 4002-4010
  • 14 Wong NK, Lai JC, Birkenhead D, Shaw AS, Johnson P. CD45 down-regulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells. J Immunol (Baltimore, Md: 1950) 2008; 181 (10) 7033-7043
  • 15 Karisch R, Fernandez M, Taylor P. , et al. Global proteomic assessment of the classical protein-tyrosine phosphatome and “Redoxome”. Cell 2011; 146 (05) 826-840
  • 16 Terstappen LW, Loken MR. Five-dimensional flow cytometry as a new approach for blood and bone marrow differentials. Cytometry 1988; 9 (06) 548-556
  • 17 Daniel JL, Dangelmaier CA, Mada S. , et al. Cbl-b is a novel physiologic regulator of glycoprotein VI-dependent platelet activation. J Biol Chem 2010; 285 (23) 17282-17291
  • 18 Ramya TN, Weerapana E, Liao L. , et al. In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics. Mol Cell Proteomics 2010; 9 (06) 1339-1351
  • 19 Tomer A. Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes. Blood 2004; 104 (09) 2722-2727
  • 20 Angelillo-Scherrer A, de Frutos P, Aparicio C. , et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001; 7 (02) 215-221
  • 21 Weiss EJ, Hamilton JR, Lease KE, Coughlin SR. Protection against thrombosis in mice lacking PAR3. Blood 2002; 100 (09) 3240-3244
  • 22 Naik MU, Stalker TJ, Brass LF, Naik UP. JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets. Blood 2012; 119 (14) 3352-3360
  • 23 Xiang B, Zhang G, Stefanini L. , et al. The Src family kinases and protein kinase C synergize to mediate Gq-dependent platelet activation. J Biol Chem 2012; 287 (49) 41277-41287
  • 24 Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006; 99 (12) 1293-1304
  • 25 Wood GS, Szwejbka P, Schwandt A. Human Langerhans cells express a novel form of the leukocyte common antigen (CD45). J Invest Dermatol 1998; 111 (04) 668-673
  • 26 Kirchberger S, Majdic O, Blüml S. , et al. The cytoplasmic tail of CD45 is released from activated phagocytes and can act as an inhibitory messenger for T cells. Blood 2008; 112 (04) 1240-1248
  • 27 Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003; 21: 107-137
  • 28 Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994; 12: 85-116
  • 29 Byth KF, Conroy LA, Howlett S. , et al. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med 1996; 183 (04) 1707-1718
  • 30 Mee PJ, Turner M, Basson MA, Costello PS, Zamoyska R, Tybulewicz VL. Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice. Eur J Immunol 1999; 29 (09) 2923-2933
  • 31 Fleming HE, Milne CD, Paige CJ. CD45-deficient mice accumulate Pro-B cells both in vivo and in vitro. J Immunol (Baltimore, Md: 1950) 2004; 173 (04) 2542-2551
  • 32 Hesslein DG, Palacios EH, Sun JC. , et al. Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases. Blood 2011; 117 (11) 3087-3095
  • 33 Zhang H, Meng F, Chu CL, Takai T, Lowell CA. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 2005; 22 (02) 235-246
  • 34 Reichert N, Seligsohn U, Ramot B. Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases. Thromb Diath Haemorrh 1975; 34 (03) 806-820
  • 35 Nair S, Ghosh K, Kulkarni B, Shetty S, Mohanty D. Glanzmann's thrombasthenia: updated. Platelets 2002; 13 (07) 387-393
  • 36 Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 2005; 3 (08) 1752-1762
  • 37 Suzuki-Inoue K, Wilde JI, Andrews RK. , et al. Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites. Biochem J 2004; 378 (Pt 3): 1023-1029
  • 38 Cheli Y, Jensen D, Marchese P. , et al. The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice. Blood 2008; 111 (03) 1266-1273
  • 39 Senis YA, Tomlinson MG, Ellison S. , et al. The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis. Blood 2009; 113 (20) 4942-4954
  • 40 Lockyer S, Okuyama K, Begum S. , et al. GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. Thromb Res 2006; 118 (03) 371-380
  • 41 Earl LA, Baum LG. CD45 glycosylation controls T-cell life and death. Immunol Cell Biol 2008; 86 (07) 608-615